内分泌检测产品市场：依产品类型、按技术、按适应症、按最终用户、按地区

内分泌检测产品市场预计到2024年将达到136.9亿美元，预计到2031年将达到253.4亿美元，2024年至2031年的复合年增长率为9.2%。

图：2024 年按地区分類的内分泌检测产品市场占有率（%）

内分泌检测产品是用于内分泌系统功能检测的体外诊断试剂。内分泌系统是由腺体组成的调节系统，将荷尔蒙直接分泌到循环系统中，以调节远处的目标器官。内分泌检测产品可帮助医生监测荷尔蒙水平并筛检内分泌失调。常见的内分泌测试包括甲状腺功能测试、睪固酮测试、雌激素测试、催乳素测试、皮质醇测试和胰岛素测试。糖尿病、甲状腺疾病和荷尔蒙失衡等内分泌相关疾病的盛行率不断上升，可能会推动全球对内分泌检测的需求。诊断技术的进步促进了临床实验室高通量内分泌检测的高灵敏度生物检测和自动化解决方案的开发。

市场动态

全球内分泌检测产品市场的成长是由越来越多的老龄化人口（更容易患内分泌疾病）、人们对内分泌疾病的认识和筛检的提高以及内分泌功能检测在疾病诊断和管理中的广泛应用推动的。然而，新产品核可的漫长而复杂的监管流程以及不愿改变现有测试程序可能会阻碍市场成长。市场正在见证先进免疫检测平台的开发带来的利润丰厚的机会，这些平台具有更高的准确性、每次测试的测试量更大以及整合的资讯学。这使得可以用小样本同时测试多种荷尔蒙。

本研究的主要特点

该报告对全球内分泌检测产品市场进行了详细分析，并提出了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球内分泌检测产品市场的主要企业进行了分析。

本研究涵盖的主要企业包括 Abbott、AB Sciex、Agilent Technologies Inc.、bioMerieux SA、Bio-Rad Laboratories Inc.、DiaSorin SpA、F. Hoffmann-La Roche Ltd.、Quest Diagnostics Inc.、Danaher、Immunodiagnostic Systems、Fujirebio 、公司等

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球内分泌检测产品市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球内分泌检测产品市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章 市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 流行病学
• 管道分析

第四章内分泌检测产品市场，依产品类型，2019-2031

• 仪器/分析仪
• 消耗品

第五章内分泌检测产品市场（依技术），2019-2031

• 液相层析法质谱法
• 免疫检测
• 串联式质谱法
• 感测器技术
• 其他的

第六章内分泌检测产品市场，依疾病适应症，2019-2031

• 肾上腺功能不全及爱迪生氏症
• 骨病
• 癌症
• 甲状腺疾病
• 其他的

第 7 章 内分泌检测产品市场，依最终使用者划分，2019-2031 年

• 医院
• 临床实验室
• 其他的

第八章内分泌检测产品市场，按地区，2019-2031

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第9章 竞争格局

• Abbott
• AB Sciex
• Agilent Technologies Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin SpA
• F.Hoffmann-La Roche Ltd.
• Quest Diagnostics Inc
• Danaher
• Immunodiagnostic Systems
• Fujirebio, Inc.

第10章分析师建议

• Wheel of Fortune
• 分析师观点
• Coherent Opportunity Map

第十一章 参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Endocrine testing product market is estimated to be valued at USD 13.69 Bn in 2024 and is expected to reach USD 25.34 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.

Figure. Endocrine Testing Product Market Share (%), By Region, 2024

Endocrine testing product refers to in vitro diagnostics that are used to test the functionality of the endocrine system. Endocrine system is a regulatory system composed of glands that secrete hormones directly into the circulatory system to regulate distant target organs. Endocrine testing products help physicians monitor hormone levels and screen for endocrine disorders. Some common endocrine tests include thyroid function tests, testosterone testing, estrogen testing, prolactin testing, cortisol testing, and insulin testing. Rising prevalence of endocrine-related diseases such as diabetes, thyroid disorders, and hormonal imbalance disorders can boost demand for endocrine testing worldwide. Advancements in diagnostic technologies have enabled the development of sensitive bioassays and automated solutions for high-throughput endocrine testing in clinical laboratories.

Market Dynamics

Global endocrine testing product market growth is driven by growing geriatric population who are more prone to developing endocrine disorders, increasing awareness and screening of endocrine conditions, and expanding applications of endocrine function tests in disease diagnosis and management. However, lengthy and complex regulatory processes for new product approvals and reluctance to change existing testing procedures can hamper the market growth. The market witness lucrative opportunities from the development of advanced immunoassay platforms with improved accuracy, high test volumes per run, and integrated informatics. This allows for the testing of multiple hormones simultaneously using small sample volumes.

Key Features of the Study

This report provides in-depth analysis of the global endocrine testing product market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global endocrine testing product market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, Immunodiagnostic Systems, and Fujirebio, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global endocrine testing product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing product market

Market Segmentation

• By Product Type Insights
  • Instruments/Analyzers
  • Consumables
• By Technology Insights
  • Liquid Chromatography-Mass Spectrometry
  • Immunoassay
  • Tandem Mass Spectroscopy
  • Sensor Technology
  • Others
• By Disease Indication Insights
  • Adrenal Insufficiency and Addison Disease
  • Bone Disorders
  • Cancer
  • Thyroid Disease
  • Others
• By End User Insights
  • Hospitals
  • Clinical Laboratories
  • Others
• Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott
  • AB Sciex
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Quest Diagnostics Inc
  • Danaher
  • Immunodiagnostic Systems
  • Fujirebio, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Endocrine Testing Product Market, By Product Type
  • Endocrine Testing Product Market, By Technology
  • Endocrine Testing Product Market, By Disease Indication
  • Endocrine Testing Product Market, By End User
  • Endocrine Testing Product Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Epidemiology
• Pipeline Analysis

4. Endocrine Testing Product Market, By Product Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Instruments/Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Endocrine Testing Product Market, By Technology, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Liquid Chromatography-Mass Spectrometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Tandem Mass Spectroscopy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Sensor Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Endocrine Testing Product Market, By Disease Indication, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Adrenal Insufficiency and Addison Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Bone Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Thyroid Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Endocrine Testing Product Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Clinical Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Endocrine Testing Product Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Technology, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AB Sciex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F.Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics Inc
• Danaher
• Immunodiagnostic Systems
• Fujirebio, Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us